GLP-1 drugs could have a surprisingly large environmental payoff
4 Articles
4 Articles
GLP-1 Drugs Could Have Major Environmental Impacts
Obesity is often described as a lifestyle disease caused by individual choices, but eating habits are also shaped by food prices, availability, marketing, convenience and the location of stores. Research discussed here argues that GLP-1 drugs may help people eat less in an unhealthy food environment, while emphasizing that lasting improvements in health and environmental [...]
A simulation of the widespread use of LPG-1 drugs suggests that reducing intake could free up to 32 million hectares of agriculture and prevent millions of deaths by 2050. The effect would be greater if the change were accompanied by healthier diets, although researchers warn that food prices, consumption and policies can alter the outcome.
GLP-1 weight-loss medicine such as Ozempic and Wegovy could affect much more than the ways of the people who take them. If wisely used, our new research suggest these appetite-suppressing medicines could transform the global food system and free up vast areas of agricultural land. The global food system is ultimate driving by demand. If
Coverage Details
Bias Distribution
- 100% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium




